UK markets open in 3 hours 28 minutes
NIKKEI 225
37,780.35 +151.87 (+0.40%) HANG SENG
17,615.74 +331.20 (+1.92%) CRUDE OIL
83.79 +0.22 (+0.26%) GOLD FUTURES
2,345.00 +2.50 (+0.11%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,480.15 +36.61 (+0.07%)
MRNA Jul 2024 150.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:53PM EDT. Market open.
| Previous close | 56.40 |
| Open | 56.40 |
| Bid | 46.85 |
| Ask | 50.85 |
| Strike | 150.00 |
| Expiry date | 2024-07-19 |
| Day's range | 56.40 - 56.40 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksAnalysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for
Moderna (MRNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Reuters
UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines. GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the COVID-19 pandemic.
Investor's Business DailyAnalysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Moderna stock is under pressure and estimates have come down for its first quarter. Is MRNA stock now a sell?
© 2024 Yahoo. All rights reserved.